Trgovina Takeda Pharmaceutical Company Limited - 4502 CFD
Dodaj med priljubljene- Povzetek
- Zgodovinski podatki
- Dogodki
- Izkaz poslovnega izida
- Bilanca stanja
- Denarni tok
- Lastništvo
Razmik | 24.66 | ||||||||
Nočna pristojbina za nakup
Long position overnight fee
Pojdi na platformo | -0.010991% | ||||||||
Nočna pristojbina za prodajo
Short position overnight fee
Pojdi na platformo | -0.011231% | ||||||||
Čas nočne pristojbine | 21:00 (UTC) | ||||||||
Min. tržena količina | 1 | ||||||||
Valuta | JPY | ||||||||
Kritje | 20% | ||||||||
Borza | Japan | ||||||||
Provizija na trgovanje | 0% |
*Information provided by Capital.com
Predhodno. Zapri* | 4298.77 |
Odpri* | 4322.91 |
Enoletna sprememba* | 24.29% |
Dnevni razpon* | 4308.95 - 4339.17 |
Razpon 52 wk | 3,495.00-4,478.00 |
Povprečni obseg (10 dni) | 5.28M |
Povprečni obseg (3 meseci) | 91.16M |
Tržna kapitalizacija | 6,882.99B |
Razmerje P/E | 24.72 |
Število delnic v obtoku | 1.55B |
Prihodki | 3,944.61B |
EPS | 175.97 |
Dividenda (donosnost v %) | 4.13793 |
Beta | 1.00 |
Datum naslednjega zaslužka | May 11, 2023 |
Vse podatke je zagotovil Refinitiv, razen podatkov, označenih z zvezdico, ki so *podatki, ki jih je zagotovil Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Zapiranje | Change | Change (%) | Odpiranje | High | Low |
---|---|---|---|---|---|---|
Mar 31, 2023 | 4338.67 | 12.87 | 0.30% | 4325.80 | 4345.85 | 4306.76 |
Mar 30, 2023 | 4298.77 | -0.70 | -0.02% | 4299.47 | 4315.83 | 4285.81 |
Mar 29, 2023 | 4350.74 | 53.76 | 1.25% | 4296.98 | 4352.54 | 4296.96 |
Mar 28, 2023 | 4273.83 | -40.00 | -0.93% | 4313.83 | 4320.92 | 4264.96 |
Mar 27, 2023 | 4277.82 | 6.38 | 0.15% | 4271.44 | 4289.80 | 4258.08 |
Mar 24, 2023 | 4254.99 | 11.77 | 0.28% | 4243.22 | 4267.86 | 4224.16 |
Mar 23, 2023 | 4252.60 | -32.31 | -0.75% | 4284.91 | 4286.90 | 4240.03 |
Mar 22, 2023 | 4358.72 | -55.75 | -1.26% | 4414.47 | 4414.47 | 4352.73 |
Mar 20, 2023 | 4283.82 | -61.23 | -1.41% | 4345.05 | 4347.74 | 4282.72 |
Mar 17, 2023 | 4369.09 | 34.51 | 0.80% | 4334.58 | 4382.66 | 4320.91 |
Mar 16, 2023 | 4273.94 | 6.88 | 0.16% | 4267.06 | 4292.79 | 4244.02 |
Mar 15, 2023 | 4332.19 | 30.12 | 0.70% | 4302.07 | 4332.19 | 4286.81 |
Mar 14, 2023 | 4265.46 | 32.02 | 0.76% | 4233.44 | 4293.29 | 4206.11 |
Mar 13, 2023 | 4279.92 | 5.49 | 0.13% | 4274.43 | 4290.30 | 4240.93 |
Mar 10, 2023 | 4335.78 | -9.97 | -0.23% | 4345.75 | 4354.23 | 4323.71 |
Mar 9, 2023 | 4388.64 | 54.76 | 1.26% | 4333.88 | 4390.64 | 4317.82 |
Mar 8, 2023 | 4323.81 | 31.92 | 0.74% | 4291.89 | 4329.90 | 4289.00 |
Mar 7, 2023 | 4289.10 | 19.16 | 0.45% | 4269.94 | 4292.89 | 4264.86 |
Mar 6, 2023 | 4260.97 | 21.94 | 0.52% | 4239.03 | 4269.45 | 4233.94 |
Mar 3, 2023 | 4237.04 | 46.28 | 1.10% | 4190.76 | 4252.40 | 4190.16 |
Takeda Pharmaceutical Company Limited Events
Čas (UTC) (UTC) | Država | Dogodek |
---|---|---|
No events scheduled |
- Letni
- Četrtletno
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Skupni prihodki | 3569010 | 3197810 | 3291190 | 2097220 | 1770530 |
Prihodki | 3569010 | 3197810 | 3291190 | 2097220 | 1770530 |
Celotni stroški prihodkov | 1106850 | 994308 | 1089760 | 651729 | 495921 |
Bruto dobiček | 2462160 | 2203500 | 2201420 | 1445500 | 1274610 |
Celotni odhodki iz poslovanja | 3123810 | 2596860 | 3193730 | 1874650 | 1531000 |
Celotna prodaja/splošni/upravni stroški Odhodki | 886361 | 875663 | 964737 | 717599 | 628106 |
Raziskave in razvoj | 526087 | 455833 | 492381 | 368298 | 325441 |
Depreciation / Amortization | 472915 | 421864 | 455420 | 178617 | 122131 |
Nenavadni odhodki (prihodki) | 100290 | -265230 | 189043 | -41201 | 28183 |
Other Operating Expenses, Total | 31309 | 114422 | 2384 | -2507 | -3907 |
Prihodki iz poslovanja | 445198 | 600952 | 97459 | 222577 | 239528 |
Prihodki (odhodki) od obresti, neto Neoperativni | -142628 | -234717 | -158213 | -94965 | -22323 |
Drugo, neto | 1 | ||||
Čisti dobiček pred obdavčitvijo | 302571 | 366235 | -60754 | 127612 | 217205 |
Čisti dobiček po davkih | 230166 | 376171 | 44290 | 135080 | 186708 |
Manjšinski delež | -107 | -166 | -49 | 112 | 178 |
Čisti dobiček pred dodatnimi postavkami | 230059 | 376005 | 44241 | 135192 | 186886 |
Čisti dobiček | 230059 | 376005 | 44241 | 135192 | 186886 |
Prihodek, ki je na razpolago navadnim delničarjem, brez dodatnih postavk | 230059 | 376005 | 44241 | 135192 | 186886 |
Prihodek, ki je na razpolago skupnemu dobičku, vključno z dodatnimi postavkami | 230059 | 376005 | 44241 | 135192 | 186886 |
Popravljen čisti dobiček | 230059 | 376005 | 44241 | 135192 | 186886 |
Popravljene ponderirane povprečne delnice | 1577.17 | 1573.54 | 1566.2 | 966.897 | 786.69 |
Popravljen dobiček na delnico brez upoštevanja izrednih postavk | 145.868 | 238.955 | 28.2473 | 139.82 | 237.56 |
Dividends per Share - Common Stock Primary Issue | 180 | 180 | 180 | 180 | 180 |
Popravljen normalizirani dobiček na enoto čistega dobička | 194.24 | 129.394 | 106.703 | 112.123 | 268.355 |
Odhodki (prihodki) od obresti - neto poslovanje | 2112 | -64872 |
Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | |
---|---|---|---|---|---|
Skupni prihodki | 1096550 | 1002310 | 972465 | 873289 | 901294 |
Prihodki | 1096550 | 1002310 | 972465 | 873289 | 901294 |
Celotni stroški prihodkov | 335973 | 305445 | 292882 | 308380 | 281404 |
Bruto dobiček | 760578 | 696862 | 679583 | 564909 | 619890 |
Celotni odhodki iz poslovanja | 949561 | 897869 | 821950 | 874908 | 784810 |
Celotna prodaja/splošni/upravni stroški Odhodki | 262299 | 248734 | 231480 | 223429 | 231078 |
Raziskave in razvoj | 174629 | 154145 | 143607 | 143628 | 128378 |
Depreciation / Amortization | 135576 | 142366 | 131277 | 149283 | 118087 |
Nenavadni odhodki (prihodki) | 14898 | 33062 | 26767 | ||
Other Operating Expenses, Total | 26186 | 47179 | 22704 | 17126 | -904 |
Prihodki iz poslovanja | 146990 | 104438 | 150515 | -1619 | 116484 |
Prihodki (odhodki) od obresti, neto Neoperativni | -39837 | -39890 | 4959 | -52429 | -44291 |
Čisti dobiček pred obdavčitvijo | 107153 | 64549 | 155473 | -54047 | 72193 |
Čisti dobiček po davkih | 119149 | 61732 | 105021 | -11375 | 57820 |
Manjšinski delež | -22 | 10 | -7 | 17 | -51 |
Čisti dobiček pred dodatnimi postavkami | 119127 | 61742 | 105014 | -11358 | 57769 |
Čisti dobiček | 119127 | 61742 | 105014 | -11358 | 57769 |
Prihodek, ki je na razpolago navadnim delničarjem, brez dodatnih postavk | 119127 | 61742 | 105014 | -11358 | 57770 |
Prihodek, ki je na razpolago skupnemu dobičku, vključno z dodatnimi postavkami | 119127 | 61742 | 105014 | -11358 | 57770 |
Popravljen čisti dobiček | 119127 | 61742 | 105014 | -11358 | 57770 |
Popravljene ponderirane povprečne delnice | 1570.42 | 1563.73 | 1545.71 | 1553.81 | 1574.97 |
Popravljen dobiček na delnico brez upoštevanja izrednih postavk | 75.857 | 39.4837 | 67.9392 | -7.30976 | 36.68 |
Dividends per Share - Common Stock Primary Issue | 0 | 90 | 0 | 90 | 0 |
Popravljen normalizirani dobiček na enoto čistega dobička | 82.0233 | 39.4837 | 67.9392 | 6.52092 | 50.2916 |
Total Adjustments to Net Income | 1 | ||||
Drugo, neto | 1 | -1 | 1 |
- Letni
- Četrtletno
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Kratkoročna sredstva skupaj | 2593640 | 2712890 | 2469430 | 2993040 | 1078810 |
Denarna sredstva in kratkoročne naložbe | 875000 | 1002820 | 653436 | 725819 | 375186 |
Denarna sredstva in ustrezniki | 389058 | 335027 | 188640 | 462890 | 243324 |
Kratkoročne naložbe | 485942 | 667793 | 464796 | 262929 | 131862 |
Celotne terjatve, neto | 724377 | 812714 | 784921 | 749119 | 428792 |
Accounts Receivable - Trade, Net | 617518 | 707487 | 670708 | 657681 | 360833 |
Total Inventory | 853167 | 753881 | 759599 | 919670 | 212944 |
Other Current Assets, Total | 141098 | 143478 | 271476 | 598429 | 61886 |
Total Assets | 13178000 | 12912300 | 12821100 | 13792800 | 4106460 |
Property/Plant/Equipment, Total - Net | 1582800 | 1453920 | 1386370 | 1331930 | 536801 |
Property/Plant/Equipment, Total - Gross | 2453010 | 2191740 | 2084120 | 1971520 | 1191400 |
Accumulated Depreciation, Total | -870208 | -737818 | -697754 | -639591 | -654597 |
Goodwill, Net | 4407750 | 4033920 | 4012530 | 4240250 | 1029250 |
Intangibles, Net | 3818540 | 3909110 | 4171360 | 4751170 | 1014260 |
Long Term Investments | 330133 | 348350 | 369455 | 299922 | 304385 |
Other Long Term Assets, Total | 445150 | 454110 | 411948 | 176463 | 142957 |
Total Current Liabilities | 2145730 | 1773180 | 2175900 | 2553050 | 737509 |
Accounts Payable | 295933 | 232105 | 211627 | 212348 | 133705 |
Notes Payable/Short Term Debt | 285 | 69 | 5014 | 500002 | 18 |
Current Port. of LT Debt/Capital Leases | 203708 | 22084 | 581803 | 484944 | |
Other Current Liabilities, Total | 1645800 | 1518920 | 1377450 | 1355760 | 603786 |
Total Liabilities | 7495000 | 7739260 | 8097610 | 8610790 | 2109040 |
Total Long Term Debt | 4141420 | 4613220 | 4506490 | 4766000 | 985644 |
Long Term Debt | 4141420 | 4613220 | 4506490 | 4766000 | 985644 |
Deferred Income Tax | 473145 | 576542 | 765079 | 783356 | 90725 |
Minority Interest | 504 | 4140 | 4003 | 4006 | 19985 |
Other Liabilities, Total | 734202 | 772180 | 646144 | 504372 | 275176 |
Total Equity | 5683020 | 5173040 | 4723480 | 5181980 | 1997420 |
Common Stock | 1676260 | 1668140 | 1668120 | 1643580 | 77914 |
Additional Paid-In Capital | 1708870 | 1688420 | 1680290 | 1650230 | 90740 |
Retained Earnings (Accumulated Deficit) | 1479720 | 1509910 | 1369970 | 1595430 | 1557310 |
Treasury Stock - Common | -116007 | -59552 | -87463 | -57142 | -74373 |
Unrealized Gain (Loss) | 22068 | 41983 | 22891 | 46380 | 73037 |
Other Equity, Total | 912106 | 324131 | 69673 | 303499 | 272799 |
Total Liabilities & Shareholders’ Equity | 13178000 | 12912300 | 12821100 | 13792800 | 4106460 |
Total Common Shares Outstanding | 1550.36 | 1563.36 | 1557.77 | 1554.78 | 781.309 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
Kratkoročna sredstva skupaj | 2593640 | 2477890 | 2456350 | 2476460 | 2712890 |
Denarna sredstva in kratkoročne naložbe | 875000 | 751896 | 633623 | 684850 | 1002820 |
Denarna sredstva in ustrezniki | 849695 | 724341 | 607881 | 654920 | 966222 |
Kratkoročne naložbe | 25305 | 27555 | 25742 | 29930 | 36598 |
Celotne terjatve, neto | 724377 | 756117 | 887295 | 858957 | 812714 |
Accounts Receivable - Trade, Net | 696644 | 715515 | 843625 | 827253 | 783091 |
Total Inventory | 853167 | 811324 | 783476 | 779148 | 753881 |
Other Current Assets, Total | 141098 | 158556 | 151959 | 153503 | 143478 |
Total Assets | 13178000 | 12698500 | 12560300 | 12657200 | 12912300 |
Property/Plant/Equipment, Total - Net | 1582800 | 1493590 | 1459920 | 1452170 | 1453920 |
Goodwill, Net | 4407750 | 4167990 | 4078370 | 4058940 | 4033920 |
Intangibles, Net | 3818540 | 3791880 | 3783680 | 3856430 | 3909110 |
Long Term Investments | 330133 | 334812 | 352091 | 374659 | 348350 |
Other Long Term Assets, Total | 445150 | 432359 | 429864 | 438578 | 454110 |
Total Current Liabilities | 2145730 | 1809250 | 1918750 | 1706780 | 1773180 |
Accounts Payable | 516297 | 351185 | 336600 | 320645 | 343838 |
Notes Payable/Short Term Debt | 285 | 0 | 0 | 0 | 69 |
Current Port. of LT Debt/Capital Leases | 203708 | 122936 | 214886 | 24272 | 22084 |
Other Current Liabilities, Total | 1425440 | 1335130 | 1367260 | 1361860 | 1407180 |
Total Liabilities | 7495000 | 7367190 | 7236340 | 7418980 | 7739260 |
Total Long Term Debt | 4141420 | 4231940 | 4016470 | 4381590 | 4613220 |
Long Term Debt | 4141420 | 4231940 | 4016470 | 4381590 | 4613220 |
Deferred Income Tax | 473145 | 589481 | 576738 | 578065 | 576542 |
Minority Interest | 504 | 493 | 426 | 385 | 4140 |
Other Liabilities, Total | 734202 | 736023 | 723951 | 752155 | 772180 |
Total Equity | 5683020 | 5331330 | 5323940 | 5238260 | 5173040 |
Common Stock | 1676260 | 1676260 | 1676260 | 1669120 | 1668140 |
Additional Paid-In Capital | 1708870 | 1697560 | 1686490 | 1682500 | 1688420 |
Retained Earnings (Accumulated Deficit) | 1479720 | 1466930 | 1551150 | 1503810 | 1509910 |
Treasury Stock - Common | -116007 | -91013 | -41037 | -42344 | -59552 |
Unrealized Gain (Loss) | 22068 | 31196 | 57646 | 41983 | |
Other Equity, Total | 912106 | 550395 | 451066 | 367516 | 324131 |
Total Liabilities & Shareholders’ Equity | 13178000 | 12698500 | 12560300 | 12657200 | 12912300 |
Total Common Shares Outstanding | 1550.36 | 1557.49 | 1572.83 | 1568.66 | 1563.36 |
- Letni
- Četrtletno
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Čisti prihodki/začetna postavka | 230166 | 376171 | 44290 | 109014 | 186708 |
Denarna sredstva iz poslovanja | 1123100 | 1010930 | 670381 | 328301 | 399200 |
Denarna sredstva iz poslovanja | 583151 | 559671 | 583649 | 272446 | 182127 |
Nedenarne postavke | 252109 | 12308 | 172928 | 39061 | -43306 |
Cash Taxes Paid | 140423 | 201687 | 226768 | 44909 | 29883 |
Denarna sredstva Plačane obresti | 108207 | 107350 | 127211 | 34914 | 8365 |
Spremembe v obratnem kapitalu | 57679 | 62781 | -130486 | -92220 | 73671 |
Denarna sredstva pri naložbenju | -198125 | 393530 | 292119 | -2835700 | -93342 |
Kapitalski izdatki | -186037 | -236468 | -217710 | -134114 | -128262 |
Celotne druge postavke denarnih tokov pri naložbenju | -12088 | 629998 | 509829 | -2701580 | 34920 |
Denarna sredstva pri financiranju | -1070260 | -1088350 | -1005210 | 2946240 | -326226 |
Postavke denarnega toka pri financiranju | -108592 | -142352 | -132804 | -71143 | -15099 |
Total Cash Dividends Paid | -283665 | -283357 | -282582 | -142952 | -141893 |
Izdaja (odplačilo) delnic, neto | -77531 | -2141 | -3737 | -1172 | -18756 |
Izdaja (odplačilo) dolga, neto | -600477 | -660504 | -586090 | 3161500 | -150478 |
Učinki deviznih tečajev | 28758 | 12501 | -21766 | -31269 | -4565 |
Neto sprememba denarnih sredstev | -116527 | 328608 | -64479 | 407571 | -24933 |
Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | |
---|---|---|---|---|---|
Net income/Starting Line | 285903 | 166753 | 105021 | 230166 | 241541 |
Cash From Operating Activities | 683463 | 305234 | 84241 | 1123100 | 747521 |
Cash From Operating Activities | 502990 | 326110 | 158283 | 583151 | 430877 |
Non-Cash Items | 218641 | 140497 | 51740 | 252109 | 187026 |
Cash Taxes Paid | 165066 | 109217 | 20855 | 140423 | 101086 |
Cash Interest Paid | 86563 | 52719 | 22770 | 108207 | 84917 |
Changes in Working Capital | -324071 | -328126 | -230803 | 57679 | -111923 |
Cash From Investing Activities | -168610 | -121920 | -94714 | -198125 | -172487 |
Capital Expenditures | -189609 | -138985 | -98376 | -186037 | -134214 |
Other Investing Cash Flow Items, Total | 20999 | 17065 | 3662 | -12088 | -38273 |
Cash From Financing Activities | -702548 | -267593 | -215717 | -1070260 | -826465 |
Financing Cash Flow Items | -92527 | -52761 | -22786 | -108592 | -85284 |
Total Cash Dividends Paid | -268997 | -140007 | -128873 | -283665 | -273024 |
Issuance (Retirement) of Stock, Net | -26929 | -26929 | -26929 | -77531 | -52538 |
Issuance (Retirement) of Debt, Net | -314095 | -47896 | -37129 | -600477 | -415619 |
Foreign Exchange Effects | 23141 | 32720 | 22485 | 28758 | 9549 |
Net Change in Cash | -164554 | -51559 | -203705 | -116527 | -241882 |
Ime vlagatelja | Vrsta vlagatelja | Odstotek neporavnanih obveznosti | Delnice v lasti | Sprememba delnic | Datum imetništva | Ocena prometa |
---|---|---|---|---|---|---|
Nomura Asset Management Co., Ltd. | Investment Advisor | 4.1084 | 65007007 | -76000 | 2023-02-28 | LOW |
Sumitomo Mitsui Trust Asset Management Co., Ltd. | Investment Advisor | 3.8571 | 61030834 | 60943076 | 2022-11-30 | LOW |
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 2.6692 | 42234586 | 57700 | 2023-02-28 | LOW |
JPMorgan Securities Japan Co., Ltd. | Research Firm | 2.3848 | 37735000 | 13609000 | 2022-09-30 | LOW |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 2.2293 | 35273592 | -840008 | 2023-02-28 | LOW |
Nikko Asset Management Co., Ltd. | Investment Advisor/Hedge Fund | 2.0544 | 32507000 | 2470629 | 2022-11-30 | LOW |
Daiwa Asset Management Co., Ltd. | Investment Advisor | 1.8823 | 29784238 | -48400 | 2023-02-28 | LOW |
Nippon Life Insurance Company | Insurance Company | 1.861 | 29447000 | -2377000 | 2022-09-30 | LOW |
Capital Research Global Investors | Investment Advisor | 1.8554 | 29358500 | 18800 | 2023-01-31 | LOW |
Norges Bank Investment Management (NBIM) | Sovereign Wealth Fund | 1.5239 | 24113047 | 1171849 | 2022-12-31 | LOW |
Takeda Science Foundation | Corporation | 1.132 | 17912000 | 0 | 2022-09-30 | LOW |
Mitsubishi UFJ Kokusai Asset Management Co., Ltd. | Investment Advisor | 0.778 | 12309837 | -65791 | 2023-02-28 | LOW |
CPP Investment Board | Pension Fund | 0.7341 | 11616000 | 7985000 | 2022-03-31 | LOW |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 0.7089 | 11216737 | 13283 | 2023-02-28 | LOW |
BlackRock Advisors (UK) Limited | Investment Advisor/Hedge Fund | 0.5202 | 8230678 | 47200 | 2023-02-28 | LOW |
BlackRock Asset Management Ireland Limited | Investment Advisor | 0.5143 | 8137797 | 8137597 | 2021-06-30 | LOW |
M & G Investment Management Ltd. | Investment Advisor | 0.4559 | 7213600 | 0 | 2023-01-31 | LOW |
Dimensional Fund Advisors, L.P. | Investment Advisor/Hedge Fund | 0.4421 | 6994953 | 16400 | 2023-02-28 | LOW |
California Public Employees' Retirement System | Pension Fund | 0.4418 | 6989926 | 722900 | 2022-06-30 | LOW |
DWS Investment GmbH | Investment Advisor/Hedge Fund | 0.4359 | 6897836 | -59516 | 2023-02-28 | LOW |
Zakaj izbrati Capital.com? Številke govorijo same zase.
Capital.com Group500K+
Borzni posredniki
92K+
Aktivne stranke mesečno
$53M+
Mesečni obseg naložb
$30M+
Dvigi vsak mesec
Kalkulator trgovanja
Izračunajte svoj hipotetični P&L, če bi trgovino s CFD odprli na določen datum (izberite datum) in jo zaprli na drug datum (izberite datum).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Takeda Pharmaceutical Company Limited Company profile
O družbi Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited je japonsko podjetje, ki se ukvarja predvsem s farmacevtsko dejavnostjo. Družba se ukvarja z raziskavami, razvojem, proizvodnjo in prodajo farmacevtskih izdelkov, splošnih medicinskih izdelkov, kvazi zdravil in zdravstvenih izdelkov na Japonskem in v tujini. Raziskovalne in razvojne funkcije družbe so osredotočene na štiri področja: onkologijo (rak), bolezni prebavil, redke bolezni in nevrologijo (nevropsihiatrične bolezni) ter na dve poslovni enoti, in sicer izdelke za frakcioniranje plazme in cepiva. Družba se ukvarja z izboljševanjem proizvodnih linij v raziskovalnih in razvojnih centrih, ki so večinoma na Japonskem in v Združenih državah Amerike.
Industry: | Pharmaceuticals (NEC) |
4階
日本橋本町二丁目1番1号
103-8668
Izkaz poslovnega izida
- Annual
- Quarterly
Ljudje gledajo tudi
Še vedno iščete posrednika, ki mu lahko zaupate?
Pridružite se 500.000+ trgovcem po vsem svetu, ki so se odločili za trgovanje s Capital.com